The global electroencephalography devices market size is expected to reach a value of USD 2.39 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 10.36% from 2024 to 2030. The high prevalence of epilepsy, sleeping disorders, brain tumors, Parkinson’s disease, and stroke among other neurological disorders is a major factor anticipated to drive the growth. According to the World Health Organization (WHO), over 50 million people are affected by epilepsy; and more than 35.6 million people worldwide are suffering from Alzheimer’s disease and dementia.
In addition, growing awareness about neurological diseases and disorders in developed and developing regions is expected to boost the market. In addition, a rise in government funding for neuroscience-related R&D is contributing to market growth to a great extent. Moreover, rapidly developing healthcare infrastructure and increasing disposable income in Asian countries are projected to support the demand for advanced electroencephalography (EEG) devices and systems.
Furthermore, the introduction of technologically advanced products such as portable electroencephalography systems is expected to drive the market. Increasing focus on neuroscience, cognitive psychology, and psychophysiological research activities has led to increased demand for advanced systems.
Request a free sample copy or view the report summary: Electroencephalography Devices Market Report
32-channel EEG systems remained the highest revenue-generating segment in 2023 attributed to robust technological advancements in 32-channel EEG products
In 2023, standalone devices accounted for the highest revenue-generating segment due to the increased application of these systems in hospitals and diagnostics centers
The hospitals segment held the largest revenue share based on end-use in 2023, owing to the increasing number of patients suffering from neurological disorders. The rising geriatric population is another major factor responsible for the segment growth
North America held the largest revenue share of the EEG system/device market in 2023. The availability of insurance coverage for brain monitoring and well-developed healthcare infrastructure is anticipated to drive the regional demand
Grand View Research has segmented the global electroencephalography devices market based on product, type, application, end-use, and region:
Electroencephalography Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
8-channel EEG
21-channel EEG
25-channel EEG
32-channel EEG
40-channel EEG
Multichannel EEG
Electroencephalography Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
Standalone Devices
Portable Devices
Wearable Devices
Electroencephalography Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Trauma & Surgery
Disease Diagnosis
Anesthesia Monitoring
Sleep Monitoring
Others
Electroencephalography Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostics Centers
Others
Electroencephalography Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Electroencephalography Devices Market
Natus Medical, Inc.
Medtronic
Nihon Kohden America, Inc.
Brain Products GmbH
Neurosoft
Compumedics Ltd.
Electrical Geodesics, Inc.
ANT Neuro
Lifelines neuro
Mitsar
Micromed
Cadwell Laboratories, Inc.
EBNeuro
Magstim EGI
Emotiv
"The quality of research they have done for us has been excellent..."